FDA’s AI Drug Development Guidelines and What’s Next for Biopharma M&A

Also: One-Third of Pharma Molecules Now Come from China, Weekly Highlights...

Hi! This is

BiopharmaTrend

’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and the great companies driving the biopharma and medtech industries forward.

If this newsletter is in your inbox, it’s because you subscribed or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button:

Let’s…